His primary scientific interests are in Internal medicine, Surgery, Cancer, Intensive care medicine and Randomized controlled trial. His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology. The various areas that Scott D. Ramsey examines in his Surgery study include Diabetes mellitus, Demography, Incidence and Risk factor.
His Cancer study combines topics from a wide range of disciplines, such as Gerontology and Family medicine. His biological study spans a wide range of topics, including MEDLINE, Regimen, Guideline, Lung and Public health. His research in Randomized controlled trial intersects with topics in Anesthesia, Thoracoscopy, Lung volume reduction surgery, Video assisted thoracic surgery and Physical therapy.
The scientist’s investigation covers issues in Internal medicine, Oncology, Cancer, Clinical trial and Intensive care medicine. His research on Internal medicine frequently connects to adjacent areas such as Surgery. As a member of one scientific family, Scott D. Ramsey mostly works in the field of Oncology, focusing on Prostate cancer and, on occasion, Gynecology.
He has included themes like Epidemiology, Disease, Gerontology and Family medicine in his Cancer study. His work focuses on many connections between Clinical trial and other disciplines, such as Randomized controlled trial, that overlap with his field of interest in Physical therapy. His Intensive care medicine study integrates concerns from other disciplines, such as Health care and MEDLINE.
Scott D. Ramsey spends much of his time researching Internal medicine, Cancer, Oncology, Clinical trial and Breast cancer. His Cancer research incorporates elements of Lung cancer, Health care and Family medicine. His work deals with themes such as Epidermal growth factor receptor and Intensive care medicine, which intersect with Lung cancer.
His research integrates issues of Genetic testing, Long term survival, Triple-negative breast cancer and MEDLINE in his study of Oncology. The study incorporates disciplines such as Biomarker, Socioeconomic status, Survival analysis and non-small cell lung cancer in addition to Clinical trial. The concepts of his Breast cancer study are interwoven with issues in Stage, Randomized controlled trial, Tumor marker and Asymptomatic.
His scientific interests lie mostly in Internal medicine, Oncology, Cancer, Clinical trial and Breast cancer. His Internal medicine study focuses mostly on Carcinoma, Disease, Chemotherapy, Randomized controlled trial and Confidence interval. His Oncology study combines topics in areas such as Quality-adjusted life year, MEDLINE, Genetic testing and Prostate cancer.
His study in Cancer is interdisciplinary in nature, drawing from both Hepatitis B, Hepatitis C virus, Young adult, Demography and Cost-effectiveness analysis. His Clinical trial research is multidisciplinary, relying on both Inclusion, Cohort study, Proportional hazards model, Survival analysis and Cohort. His Breast cancer study incorporates themes from Stage and Logistic regression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Asad Umar;C. Richard Boland;Jonathan P. Terdiman;Sapna Syngal.
Journal of the National Cancer Institute (2004)
Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
Karen Kelly;John Crowley;Paul A. Bunn;Cary A. Presant.
Journal of Clinical Oncology (2001)
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
Scott D. Ramsey;Katherine Newton;David Blough;David K. McCulloch.
Diabetes Care (1999)
THE CASE FOR EARLY DETECTION
Ruth Etzioni;Nicole Urban;Scott Ramsey;Martin McIntosh.
Nature Reviews Cancer (2003)
The economic burden of COPD.
Sean D. Sullivan;Scott D. Ramsey;Todd A. Lee.
Effect of Improved Glycemic Control on Health Care Costs and Utilization
Edward H. Wagner;Nirmala Sandhu;Katherine M. Newton;David K. McCulloch.
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
Scott Ramsey;Richard Willke;Andrew Briggs;Ruth Brown.
Value in Health (2005)
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
Christopher R. Flowers;Jerome Seidenfeld;Eric J. Bow;Clare Karten.
Journal of Clinical Oncology (2013)
Breast Cancer in Limited‐Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines
Benjamin O. Anderson;Roman Shyyan;Alexandru Eniu;Robert A. Smith.
Breast Journal (2006)
Quality of life in survivors of colorectal carcinoma.
Scott D. Ramsey;Scott D. Ramsey;M. Robyn Andersen;Ruth Etzioni;Carol Moinpour.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: